It is known that ADMA contributes to the development of hypertension in two ways: by inhibiting the activity of eNOS, which causes vasoconstriction, and by reducing renal NO synthesis, which may lead to suppression of sodium excretion by the kidneys (Oliva-Damaso et al. 2019). Here, NOS3 is linked to hypertensive disorder.